$URG
UR-ENERGY INC Stock $urg

$urg Overview Financials Valuation SEC Filings Company Website

2021 Q2 Form 10-Q Financial Statement

#000165495421008443 Filed on August 03, 2021

Income Statement

Concept	2021 Q2	2020 Q2
Revenue	$7.000K	$6.934M
YoY Change	-99.9%	-39.59%
Cost Of Revenue	$1.835M	$6.517M
YoY Change	-71.84%	-41.62%
Gross Profit	-$1.828M	$417.0K
YoY Change	-538.37%	31.96%
Gross Profit Margin	-26114.29%	6.01%
Selling, General & Admin	$1.628M	$1.190M
YoY Change	36.81%	3.48%
% of Gross Profit		285.37%
Research & Development	$1.026M	$343.0K
YoY Change	199.13%	17.47%
% of Gross Profit		82.25%
Depreciation & Amortization	$949.0K	$1.050M
YoY Change	-9.62%	-4.55%
% of Gross Profit		251.8%
Operating Expenses	$2.777M	$2.227M
YoY Change	24.7%	662.67%
Operating Profit	-$4.605M	-$1.810M
YoY Change	154.42%	2.67%
Interest Expense	$187.0K	$195.0K
YoY Change	-4.1%	-169.64%
% of Operating Profit
Other Income/Expense, Net	$1.000K	$17.00K
YoY Change	-94.12%	13.33%
Pretax Income	-$6.879M	-$2.230M
YoY Change	208.48%	9.85%
Income Tax
% Of Pretax Income
Net Earnings	-$6.879M	-$2.227M
YoY Change	208.89%	9.65%
Net Earnings / Revenue	-98271.43%	-32.12%
Basic Earnings Per Share	-$0.04	-$0.02
Diluted Earnings Per Share	-$0.04	-$13.90K
COMMON SHARES
Basic Shares Outstanding	190.2M shares
Diluted Shares Outstanding	190.2M shares	160.5M shares

Balance Sheet

Concept	2021 Q2	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.49M	$5.600M
YoY Change	283.77%	-13.85%
Cash & Equivalents	$21.49M	$5.567M
Short-Term Investments
Other Short-Term Assets	$3.473M	$1.000M
YoY Change	247.3%	-9.09%
Inventory	$7.922M	$7.485M
Prepaid Expenses	$1.060M	$969.0K
Receivables	$5.000K	$0.00
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$24.97M	$14.03M
YoY Change	77.99%	-4.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.00M	$22.81M
YoY Change	-7.93%	-66.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$15.78M	$7.500M
YoY Change	110.43%	-21.05%
Total Long-Term Assets	$72.54M	$72.23M
YoY Change	0.43%	-7.87%
TOTAL ASSETS
Total Short-Term Assets	$24.97M	$14.03M
Total Long-Term Assets	$72.54M	$72.23M
Total Assets	$97.51M	$86.26M
YoY Change	13.04%	-7.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$652.0K	$598.0K
YoY Change	9.03%	-0.33%
Accrued Expenses	$2.104M	$1.700M
YoY Change	23.76%	-10.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$1.683M
YoY Change	-100.0%	-67.63%
Total Short-Term Liabilities	$5.777M	$4.013M
YoY Change	43.96%	-47.88%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$11.46M
YoY Change	-100.0%	63.71%
Other Long-Term Liabilities	$37.84M	$498.0K
YoY Change	7497.99%	-98.46%
Total Long-Term Liabilities	$50.14M	$43.29M
YoY Change	15.82%	9.87%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.777M	$4.013M
Total Long-Term Liabilities	$50.14M	$43.29M
Total Liabilities	$55.92M	$47.30M
YoY Change	18.21%	0.43%
SHAREHOLDERS EQUITY
Retained Earnings	-$194.4M	-$171.3M
YoY Change	13.53%
Common Stock	$20.93M	$206.5M
YoY Change	-89.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$41.59M	$38.96M
YoY Change
Total Liabilities & Shareholders Equity	$97.51M	$86.26M
YoY Change	13.04%	-7.35%

Cashflow Statement

Concept	2021 Q2	2020 Q2
OPERATING ACTIVITIES
Net Income	-$6.879M	-$2.227M
YoY Change	208.89%	9.65%
Depreciation, Depletion And Amortization	$949.0K	$1.050M
YoY Change	-9.62%	-4.55%
Cash From Operating Activities	-$3.711M	-$930.0K
YoY Change	299.03%	-124.09%
INVESTING ACTIVITIES
Capital Expenditures	-$39.00K	-$10.00K
YoY Change	290.0%	-90.91%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$20.00K
YoY Change	-100.0%
Cash From Investing Activities	-$39.00K	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$4.680M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	7.631M	890.0K
YoY Change	757.42%	-177.39%
NET CHANGE
Cash From Operating Activities	-3.711M	-930.0K
Cash From Investing Activities	-39.00K	0.000
Cash From Financing Activities	7.631M	890.0K
Net Change In Cash	3.881M	-40.00K
YoY Change	-9802.5%	-101.54%
FREE CASH FLOW
Cash From Operating Activities	-$3.711M	-$930.0K
Capital Expenditures	-$39.00K	-$10.00K
Free Cash Flow	-$3.672M	-$920.0K
YoY Change	299.13%	-123.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	195407043	shares
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21491000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4268000	USD
CY2021Q2	us-gaap	Receivables Net Current ReceivablesNetCurrent	5000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	0	USD
CY2021Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1060000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	814000	USD
CY2021Q2	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	2413000	USD
CY2020Q4	us-gaap	Assets Held For Sale Not Part Of Disposal Group Current AssetsHeldForSaleNotPartOfDisposalGroupCurrent	0	USD
CY2021Q2	us-gaap	Assets Current AssetsCurrent	24969000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	5082000	USD
CY2021Q2	us-gaap	Inventory Noncurrent InventoryNoncurrent	7922000	USD
CY2020Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	7814000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7860000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7859000	USD
CY2021Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	35754000	USD
CY2020Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	39184000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21004000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21891000	USD
CY2021Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	72540000	USD
CY2020Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	76748000	USD
CY2021Q2	us-gaap	Assets Assets	97509000	USD
CY2020Q4	us-gaap	Assets Assets	81830000	USD
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2680000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2320000	USD
CY2021Q2	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	459000	USD
CY2021Q2	urg	Current Portion Of Warrant Liability CurrentPortionOfWarrantLiability	2146000	USD
CY2020Q4	urg	Current Portion Of Warrant Liability CurrentPortionOfWarrantLiability	729000	USD
CY2021Q2	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	76000	USD
CY2020Q4	us-gaap	Accrued Reclamation Costs Current AccruedReclamationCostsCurrent	76000	USD
CY2021Q2	us-gaap	Real Estate Liabilities Associated With Assets Held For Development And Sale RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale	875000	USD
CY2020Q4	us-gaap	Real Estate Liabilities Associated With Assets Held For Development And Sale RealEstateLiabilitiesAssociatedWithAssetsHeldForDevelopmentAndSale	0	USD
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	5777000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3584000	USD
CY2021Q2	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	12300000	USD
CY2020Q4	us-gaap	Notes Payable To Bank Noncurrent NotesPayableToBankNoncurrent	12720000	USD
CY2021Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16000	USD
CY2020Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	29965000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	50000	USD
CY2021Q2	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	29336000	USD
	us-gaap	Revenues Revenues	7000	USD
CY2021Q2	urg	Warrant Liabilitynoncurrent WarrantLiabilitynoncurrent	8486000	USD
CY2020Q4	urg	Warrant Liabilitynoncurrent WarrantLiabilitynoncurrent	1415000	USD
CY2021Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	50138000	USD
CY2020Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	44150000	USD
CY2021Q2	us-gaap	Partners Capital PartnersCapital	211128000	USD
CY2020Q4	us-gaap	Partners Capital PartnersCapital	189620000	USD
CY2021Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20934000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	20946000	USD
CY2021Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3960000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3707000	USD
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-194428000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-180177000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	41594000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34096000	USD
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	97509000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81830000	USD
CY2021Q2	us-gaap	Revenues Revenues	7000	USD
CY2020Q2	us-gaap	Revenues Revenues	6934000	USD
	us-gaap	Revenues Revenues	8304000	USD
CY2021Q2	us-gaap	Cost Of Revenue CostOfRevenue	1835000	USD
CY2020Q2	us-gaap	Cost Of Revenue CostOfRevenue	6517000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	3508000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	9622000	USD
CY2021Q2	us-gaap	Gross Profit GrossProfit	-1828000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	417000	USD
	us-gaap	Gross Profit GrossProfit	-3501000	USD
	us-gaap	Gross Profit GrossProfit	-1318000	USD
CY2021Q2	us-gaap	Operating Expenses OperatingExpenses	2777000	USD
CY2020Q2	us-gaap	Operating Expenses OperatingExpenses	2227000	USD
	us-gaap	Operating Expenses OperatingExpenses	4589000	USD
	us-gaap	Operating Expenses OperatingExpenses	4289000	USD
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-4605000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1810000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8090000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-5607000	USD
CY2021Q2	us-gaap	Interest Expense InterestExpense	187000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	195000	USD
	us-gaap	Interest Expense InterestExpense	376000	USD
	us-gaap	Interest Expense InterestExpense	327000	USD
CY2021Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	2920000	USD
CY2020Q2	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	231000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	6324000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-42000	USD
CY2021Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-71000	USD
CY2020Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-8000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-367000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	7000	USD
CY2021Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	904000	USD
CY2020Q2	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	17000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	906000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	17000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-6879000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-2227000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14251000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4268000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	490000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5868000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	34000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	4000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	253000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	31000	USD
CY2021Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-6845000	USD
CY2020Q2	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-2223000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-13998000	USD
	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	3508000	USD
CY2020	us-gaap	Valuation Allowances And Reserves Period Increase Decrease ValuationAllowancesAndReservesPeriodIncreaseDecrease	7802000	USD
CY2021Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	7860000	USD
CY2020Q4	urg	Cash Pledged For Reclamation CashPledgedForReclamation	7859000	USD
CY2020Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	7859000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	7814000	USD
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	464000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	3508000	USD
	us-gaap	Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax	-5837000	USD
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2021Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2020Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.04
CY2021Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	190240544	shares
CY2020Q2	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	160478059	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	186089756	shares
	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	160478059	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	190240544	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160478059	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	186089756	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	160478059	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	44333000	USD
CY2020Q1	urg	Stock Compensation StockCompensation	234000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-3614000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	40953000	USD
CY2020Q2	urg	Stock Compensation StockCompensation	230000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	-2223000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	38960000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	34096000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1078000	USD
CY2021Q1	urg	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	551000	USD
CY2021Q1	urg	Shares Issued For Cash Amount SharesIssuedForCashAmount	15237000	USD
CY2021Q1	urg	Less Amount Assigned To Warrant Liablity LessAmountAssignedToWarrantLiablity	-2604000	USD
CY2021Q1	urg	Less Share Issue Costs LessShareIssueCosts	-1307000	USD
CY2021Q1	urg	Stock Compensation StockCompensation	231000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	-7153000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	40129000	USD
CY2021Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	94000	USD
CY2021Q2	urg	Exercise Of Warrants Amount ExerciseOfWarrantsAmount	1245000	USD
CY2021Q2	urg	Shares Issued For Cash Amount SharesIssuedForCashAmount	6930000	USD
CY2021Q2	urg	Less Share Issue Costs LessShareIssueCosts	-218000	USD
CY2021Q2	urg	Stock Compensation StockCompensation	259000	USD
CY2021Q2	us-gaap	Profit Loss ProfitLoss	-6845000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-14251000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-5868000	USD
	us-gaap	Other Noncash Expense OtherNoncashExpense	4456000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1017000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1254000	USD
	us-gaap	Depreciation Depreciation	892000	USD
	us-gaap	Depreciation Depreciation	910000	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	246000	USD
	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	288000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	24000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	35000	USD
	urg	Gain On Loan Forgiveness GainOnLoanForgiveness	-903000	USD
CY2020	urg	Mineral Properties MineralProperties	0	USD
	urg	Net Assets Held For Sale NetAssetsHeldForSale	1538000	USD
CY2021Q2	urg	Current Portion Of Inventory CurrentPortionOfInventory	7922000	USD
CY2020Q4	urg	Current Portion Of Inventory CurrentPortionOfInventory	7814000	USD
CY2021Q2	us-gaap	Inventory Net InventoryNet	7922000	USD
	urg	Reclassify Assets Held For Sale ReclassifyAssetsHeldForSale	-2413000	USD
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	-1017000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	39294000	USD
CY2021Q2	urg	Accumulated Depreciations AccumulatedDepreciations	-18290000	USD
CY2021Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21004000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	39311000	USD
CY2020Q4	urg	Accumulated Depreciations AccumulatedDepreciations	-17420000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21891000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	396000	USD
CY2021Q2	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1829000	USD
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1767000	USD
CY2021Q2	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	199000	USD
CY2020Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	157000	USD
CY2021Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2680000	USD
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2320000	USD
CY2021Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	502000	USD
CY2020Q4	urg	Deferred Financing Costs DeferredFinancingCosts	-43000	USD
CY2021Q2	us-gaap	Loans Payable Current LoansPayableCurrent	0	USD
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	459000	USD
CY2021Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	398000	USD
CY2020Q4	urg	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	12441000	USD
CY2021Q2	urg	Long Term Debt Noncurrent Gross LongTermDebtNoncurrentGross	12441000	USD
CY2020Q4	urg	Deferred Financing Cost Long Term DeferredFinancingCostLongTerm	-119000	USD
CY2021Q2	us-gaap	Long Term Loans Payable LongTermLoansPayable	12300000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	12720000	USD
	urg	Gain On Loan Forgiveness GainOnLoanForgiveness	0	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	369000	USD
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-7000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-5000	USD
	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	14068000	USD
	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	14000	USD
	urg	Provision For Reclamation ProvisionForReclamation	0	USD
	urg	Provision For Reclamation ProvisionForReclamation	3000	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	6324000	USD
	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-42000	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	USD
	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-16000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3616000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-4515000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-246000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-67000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	360000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	36000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5791000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3055000	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	0	USD
	us-gaap	Increase Decrease In Deposit Other Assets IncreaseDecreaseInDepositOtherAssets	5000	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	0	USD
	us-gaap	Proceeds From Sales Of Assets Investing Activities ProceedsFromSalesOfAssetsInvestingActivities	18000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	34000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-39000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-21000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	22167000	USD
	urg	Proceeds From Exercise Of Warrants And Stock Options ProceedsFromExerciseOfWarrantsAndStockOptions	0	USD
	urg	Share Issue Costs ShareIssueCosts	-1525000	USD
	urg	Share Issue Costs ShareIssueCosts	0	USD
	urg	Proceeds From Exercise Of Warrants And Stock Options ProceedsFromExerciseOfWarrantsAndStockOptions	2359000	USD
	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	0	USD
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	893000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	23001000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	893000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	53000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-2000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17224000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2185000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12127000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15215000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29351000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13030000	USD
	us-gaap	Nature Of Operations NatureOfOperations	<table cellpadding="0" style="border-spacing:0;font-size:10pt;font-variant:normal;font-weight:normal;font-style:normal;text-align:left;line-height:normal;width:100%"><tbody><tr style="height:15px"><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>1. </strong></p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Nature of Operations</strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Ur-Energy Inc. (the “Company”) was incorporated on March 22, 2004 under the laws of the Province of Ontario. The Company continued under the Canada Business Corporations Act on August 8, 2006. The Company is an Exploration Stage mining company, as defined by United States Securities and Exchange Commission (“SEC”). The Company is engaged in uranium mining and recovery operations, with activities including the acquisition, exploration, development, and production of uranium mineral resources located primarily in Wyoming. The Company commenced uranium production at its Lost Creek Project in Wyoming in 2013.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Due to the nature of the uranium mining methods used by the Company on the Lost Creek Property, and the definition of “mineral reserves” under National Instrument 43-101 (“NI 43-101”), which uses the Canadian Institute of Mining, Metallurgy and Petroleum (“CIM”) Definition Standards, the Company has not determined whether the properties contain mineral reserves. However, the Company’s “<em>Amended Preliminary Economic Assessment of the Lost Creek Property, Sweetwater County, Wyoming,</em>” February 8, 2016 (“Lost Creek PEA”) outlines the potential viability of the Lost Creek Property. The recoverability of amounts recorded for mineral properties is dependent upon the discovery of economic resources, the ability of the Company to obtain the necessary financing to develop the properties and upon attaining future profitable production from the properties or sufficient proceeds from disposition of the properties.</p></td></tr></tbody></table>
	us-gaap	Accretion Expense AccretionExpense	246000	USD
CY2021Q2	us-gaap	Asset Retirement Obligation AssetRetirementObligation	29336000	USD
	urg	Beginning Balance Warrant Liabilities BeginningBalanceWarrantLiabilities	2144000	USD
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2604000	USD
	urg	Warrants Exercised WarrantsExercised	-609000	USD
	urg	Mark To Market Revaluation Loss Gain MarkToMarketRevaluationLossGain	6324000	USD
	urg	Ending Balance Warrant Liabilities EndingBalanceWarrantLiabilities	10632000	USD
CY2021Q2	us-gaap	Malpractice Loss Contingency Accrual Discounted Current MalpracticeLossContingencyAccrualDiscountedCurrent	2146000	USD
CY2021Q2	urg	Warrants Liability WarrantsLiability	8486000	USD
CY2021Q2	urg	Warrant Liability Duration Total WarrantLiabilityDurationTotal	10632000	USD
CY2021Q1	us-gaap	Accelerated Share Repurchases Initial Price Paid Per Share AcceleratedShareRepurchasesInitialPricePaidPerShare	0.90
CY2021Q1	urg	Options Granted OptionsGranted	2208330	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	16930530	shares
CY2021Q1	urg	Common Shares Purchase CommonSharesPurchase	8465265	shares
CY2021Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	15200000	USD
CY2021Q1	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	13900000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	800000	USD
CY2021Q1	urg	Shares Issued Upon Public Offering SharesIssuedUponPublicOffering	16930530	shares
	urg	Remaining Weighted Average Vesting Period RemainingWeightedAverageVestingPeriod	P1Y10M24D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.59
CY2021Q2	urg	Number Of Options Outstanding NumberOfOptionsOutstanding	9807551	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested	7602650000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	4728345	shares
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y9M18D
	urg	Aggregate Intrinsic Value Exercisable AggregateIntrinsicValueExercisable	3421599000	USD
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9807551	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberBeginning	1404962	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Beginning ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueBeginning	0.54
	urg	Number Of Rsus Forfeited NumberOfRsusForfeited	-59843	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	0.56
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumberEnding	1345119	shares
	urg	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Ending ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueEnding	0.57
	us-gaap	Share Based Compensation ShareBasedCompensation	300000	USD
CY2021Q1	urg	Class Of Warrant Or Right Exercise Price Of Warrants ClassOfWarrantOrRightExercisePriceOfWarrants	1.3
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	1345119	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P0Y10M24D
CY2019	urg	Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate	0.048	pure
CY2020	urg	Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad	0.63
CY2019	urg	Restricted Share Unit Fair Value Assumptions Grant Date Fair Value Cad RestrictedShareUnitFairValueAssumptionsGrantDateFairValueCad	0.79
CY2018Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	13062878	shares
CY2018Q3	urg	Common Shares Purchase CommonSharesPurchase	6531439	shares
CY2020Q3	urg	Common Stock No Par Values CommonStockNoParValues	0.75
CY2021Q1	urg	Common Shares Purchase CommonSharesPurchase	8465265	shares
	urg	Class Of Warrant Or Right Outstanding Beginning ClassOfWarrantOrRightOutstandingBeginning	22062878	shares
	urg	Class Of Warrants Or Right Shares Issued On Exercise Beginning ClassOfWarrantsOrRightSharesIssuedOnExerciseBeginning	11031439	shares
	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Beginning ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Beginning	0.90
	urg	Outstanding Warrants Issued OutstandingWarrantsIssued	16930530	shares
	urg	Number Of Shares To Be Issued Upon Exercise Issued NumberOfSharesToBeIssuedUponExerciseIssued	8465265	shares
	urg	Per Share Exercise Price Issued PerShareExercisePriceIssued	1.35
	urg	Number Of Warrants Exercised NumberOfWarrantsExercised	-2613274	shares
	urg	Number Of Shares To Be Issued Upon Exercise Exercised NumberOfSharesToBeIssuedUponExerciseExercised	-1306637	shares
	urg	Per Share Exercise Price Exercised PerShareExercisePriceExercised	0.91
	urg	Class Of Warrant Or Right Outstanding Ending ClassOfWarrantOrRightOutstandingEnding	36380134	shares
	urg	Class Of Warrants Or Right Shares Issued On Exercise Ending ClassOfWarrantsOrRightSharesIssuedOnExerciseEnding	18190067	shares
	urg	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Ending ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1Ending	1.11
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000	pure
	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	1.000	pure
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	8304000	USD
	us-gaap	Sale Of Stock Percentage Of Ownership After Transaction SaleOfStockPercentageOfOwnershipAfterTransaction	1.000	pure
	urg	Cost Of Product Sales CostOfProductSales	0	USD
	urg	Cost Of Product Sales CostOfProductSales	5166000	USD
	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	3508000	USD
	urg	Lower Of Cost Or Nrv Adjustments LowerOfCostOrNRVAdjustments	4456000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3508000	USD
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	21491000	USD
	urg	Mineral Properties MineralProperties	2413000	USD
	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	875000	USD
CY2020	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	0	USD
CY2020	urg	Net Assets Held For Sale NetAssetsHeldForSale	0	USD
CY2020Q2	us-gaap	Exploration Expense ExplorationExpense	554000	USD
	us-gaap	Exploration Expense ExplorationExpense	1156000	USD
	us-gaap	Exploration Expense ExplorationExpense	945000	USD
CY2021Q2	us-gaap	Development Costs DevelopmentCosts	333000	USD
CY2020Q2	us-gaap	Development Costs DevelopmentCosts	343000	USD
	us-gaap	Development Costs DevelopmentCosts	465000	USD
	us-gaap	Development Costs DevelopmentCosts	616000	USD
CY2021Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1628000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1185000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2722000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2439000	USD
CY2021Q2	us-gaap	Accretion Expense AccretionExpense	123000	USD
CY2020Q2	us-gaap	Accretion Expense AccretionExpense	145000	USD
	us-gaap	Accretion Expense AccretionExpense	246000	USD
	us-gaap	Accretion Expense AccretionExpense	289000	USD
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2777000	USD
CY2020Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	2227000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4589000	USD
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4289000	USD
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	29351000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12127000	USD
CY2021Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	200000	USD
CY2020Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	200000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	400000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	400000	USD
CY2021Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	500000	USD
CY2021Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	2700000	USD
CY2021Q2	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	21500000	USD
CY2020Q4	us-gaap	Mineral Properties Net MineralPropertiesNet	39184000	USD
CY2021Q2	us-gaap	Mineral Properties Net MineralPropertiesNet	35754000	USD
CY2021Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	652000	USD
	urg	Payroll Costs Description PayrollCostsDescription	Spend not less than 60% of loan proceeds on eligible payroll costs.
	urg	Additional Eligible Payroll Percentage AdditionalEligiblePayrollPercentage	0.60	pure
CY2021Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	903000	USD
CY2020Q4	us-gaap	Debt Current DebtCurrent	0	USD
CY2021Q2	us-gaap	Debt Current DebtCurrent	0	USD
CY2021Q2	urg	Deferred Financing Cost Long Term DeferredFinancingCostLongTerm	-141000	USD
CY2021	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	358000	USD
CY2022	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	3325000	USD
CY2023	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	5934000	USD
CY2024	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	4451000	USD
	urg	Reclassify Liabilities Associated With Assets Held For Sale ReclassifyLiabilitiesAssociatedWithAssetsHeldForSale	-875000	USD
	us-gaap	Foreign Currency Transaction Gain Before Tax ForeignCurrencyTransactionGainBeforeTax	169000	USD
CY2021Q1	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	16930530	shares
CY2016	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.056	pure
CY2019	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.062	pure
	us-gaap	Share Based Compensation ShareBasedCompensation	300000	USD
CY2021Q2	urg	Number Of Options Exercisable NumberOfOptionsExercisable	4728345	shares
	urg	Schedule Of Stock Option Fair Value Assumptionstabletextblock ScheduleOfStockOptionFairValueAssumptionstabletextblock	<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:92%"><tbody><tr style="height:15px;background-color:#ffffff"><td style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Stock Option Fair Value Assumptions </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2019 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2018 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2017 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2016 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected forfeiture rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.1</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">6.2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.8% - 6.0</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">5.3% - 6.0</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">5.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected life (years) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.9</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">3.7 - 3.8 </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected volatility </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">63.2</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">58.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">53.8% - 55.0 </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">56.0% - 57.5 </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">56.8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk free rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.6</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.9% -2.1</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">1.0% - 1.6</p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px">%</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected dividend rate </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Black-Scholes value (CAD$) </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">$0.30</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">$0.35</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">$0.33 - $0.39</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td/><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:right;">$0.32 - $0.44</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"/><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">$0.31</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2020	urg	Sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpected Forfeiture Rate SharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedForfeitureRate	0.061	pure
CY2020	urg	Expected Life Years ExpectedLifeYears	P3Y10M24D
CY2019	urg	Expected Life Years ExpectedLifeYears	P3Y8M12D
CY2016	urg	Expected Life Years ExpectedLifeYears	P3Y8M12D
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.632	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.586	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.568	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.004	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.016	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.010	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2016	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2020	urg	Black Scholes Value Cad BlackScholesValueCad	0.30
CY2019	urg	Black Scholes Value Cad BlackScholesValueCad	0.35
CY2016	urg	Black Scholes Value Cad BlackScholesValueCad	0.31
CY2021Q1	us-gaap	Costs And Expenses CostsAndExpenses	1350000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	1883167000	USD
CY2020	urg	Restricted Share Unit Fair Value Assumptions Expected Forfeiture Rate RestrictedShareUnitFairValueAssumptionsExpectedForfeitureRate	0.042	pure
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7000	USD
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4000	USD
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	0.000	pure
	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	7000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	9622000	USD
CY2021Q2	us-gaap	Exploration Expense ExplorationExpense	693000	USD
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7860000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7859000	USD

Files In Submission

Name	View Source	Status
0001654954-21-008443-index-headers.html	Edgar Link	pending
0001654954-21-008443-index.html	Edgar Link	pending
0001654954-21-008443.txt	Edgar Link	pending
0001654954-21-008443-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
urg-20210630.xsd	Edgar Link	pending
urg-20210630_cal.xml	Edgar Link	unprocessable
urg-20210630_def.xml	Edgar Link	unprocessable
urg-20210630_lab.xml	Edgar Link	unprocessable
urg-20210630_pre.xml	Edgar Link	unprocessable
urg_10q.htm	Edgar Link	pending
urg_10q_htm.xml	Edgar Link	completed
urg_ex311.htm	Edgar Link	pending
urg_ex312.htm	Edgar Link	pending
urg_ex321.htm	Edgar Link	pending
urg_ex322.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$URG
UR-ENERGY INC Stock $urg

2021 Q2 Form 10-Q Financial Statement

#000165495421008443 Filed on August 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG UR-ENERGY INC Stock $urg

2021 Q2 Form 10-Q Financial Statement

#000165495421008443 Filed on August 03, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$URG
UR-ENERGY INC Stock $urg